| CMGSX | VMGMX | CMGSX / VMGMX | |
| Total Expense Ratio | 1.05 | 0.07 | 1,500% |
| Annual Report Gross Expense Ratio | 1.14 | 0.07 | 1,629% |
| Fund Existence | 30 years | 15 years | - |
| Gain YTD | 11.546 | 9.952 | 116% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 3000 | 167% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.61B | 33.8B | 17% |
| Annual Yield % from dividends | 0.00 | 0.62 | - |
| Returns for 1 year | -10.25 | 11.76 | -87% |
| Returns for 3 years | 14.60 | 55.53 | 26% |
| Returns for 5 years | -19.00 | 31.10 | -61% |
| Returns for 10 years | 135.64 | 213.13 | 64% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TEMUX | 22.59 | N/A | N/A |
| Morgan Stanley Pathway Em Mkts Eq | |||
| MRICX | 26.84 | N/A | N/A |
| MFS Research International C | |||
| ICSSX | 16.85 | N/A | N/A |
| VY® Columbia Small Cp Val & InflectionS | |||
| ALVDX | 11.09 | N/A | N/A |
| American Century Focused Lg Cap Val R6 | |||
| BRUMX | 18.35 | N/A | N/A |
| MFS Blended Research Value Equity R4 | |||